STRANTLIVE 250MG INJECTION

Form: Injection

Pack Size: 1 PFS

Marketed by: ONCOBIOTEK FORMULATIONS PVT LTD (ONCOLOGY DIV)

MRP: ₹4770.00

ONCOBIOTEK FORMULATIONS PVT LTD (ONCOLOGY DIV): Strantlive 250MG Injection, 1 PFS, salt fulvestrant 250mg. NPPA has revised its MRP from Rs 18,200 to Rs 4,770 (74% lower) with effect from 09-11-2026; trade rate Rs 3,634.29. Group: oestrogen receptor degrader (hormone therapy). Same salt is also supplied by Emcure, Glenmark, Hetero, Natco, Samarth. Handling/counselling: slow intramuscular injection into the buttock; the usual dose is two 5 ml syringes; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.